An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.This report is being filed on an international product, list number 04j27-37, that has a similar product distributed in the us, list number 02p36.
|
The complaint investigation for architect hiv ag/ab combo quality control exposure included a review of information provided by the customer, a search for similar complaints, ticket trending review, labeling review, and device history record review.While preparing the hiv ag/ab combo control material, they noticed a few drops of control material splashed on their face.The customer washed their face with plenty of water.The customer did not receive any treatment for the exposure.No subsequent issues have been reported.Device history record review did not identify any non-conformances or deviations with the likely cause lot and complaint issue.Manufacturing documentation for the likely cause lot was reviewed and did not identify any issues.Labeling was reviewed and sufficiently addresses the issue.Based on the information provided and abbott diagnostics¿ complaint investigation, the architect hiv ag/ab combo is performing as intended at the customer site, and no systemic issue or deficiency was identified.Concomitant product section updated to correct the hiv control lot number.
|